Delivery Order SPE2DB22D2005-SPE2DB25FJQJ0
- Not listed
- The Defense Logistics Agency awarded a $6,383.18 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen pharmaceutical supplies, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract contains no set-aside designation...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,641.17 for Mounjaro 7.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single shipment of this diabetes medication to support federal medical...
- This is a delivery order awarded by the Defense Logistics Agency Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,480.30 firm fixed-price contract is for the supply of Mounjaro 7.5 mg/0.5 ml pen 0.5 ml, a medication used for the treatment of diabetes. The contract has a period of performance through December 18, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $1,360.45 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The contract was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, and is classified as a firm fixed price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,700.12 on July 28, 2025, for the supply of Mounjaro 12.5 mg/0.5 ml pen injections. This firm fixed price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 29, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,408.25 on July 28, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. This non-competitive delivery order, with a completion date of July 29, 2025, will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract utilizes firm fixed pricing and represents a child order under a larger contract vehicle supporting federal medical procurement needs. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens with a firm fixed price ceiling value of $27,918.05 and ultimate completion date of August 6, 2025. This non-set-aside contract represents a single delivery order for the diabetes medication, to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,720.90 on July 28, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $10,834.81 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $1,088.36 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen medication on July 25, 2025, with completion targeted for July 28, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJQJ0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,607.06 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. This competitively awarded, firm fixed price contract was executed on July 24, 2025, with an ultimate completion date of July 25, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements through open competition. As a prime contractor under the DLA Troop Support Medical program, AmerisourceBergen supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and comprehensive contract vehicles designed to ensure reliable access to essential pharmaceutical products for federal medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/24/25 |